nrx-101
Generic: D-cycloserine and lurasidone
nrx-101: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NRX Pharmaceuticals Inc. (NRXP) | Preclinical |
Get deeper analysis on nrx-101
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis